10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2023-02-14 (Q4 2022) | Holdings: 70 | Value: $4.9B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | Reduce 8% $(74.6M) | 17.23% | $849.7M | +60.32% | -12.79% | +32.91% | |
| PCVX - VAXCYTE INC | Add 28% ($61.2M) | 5.70% | $280.9M | -18.18% | +18.41% | +76.37% | |
| AVTE - AEROVATE THERAPEUTICS INC | 4.91% | $242.1M | -11.17% | -8.81% | |||
| DICE - DICE THERAPEUTICS INC | Add 31% ($51.2M) | 4.33% | $213.7M | +18.77% | |||
| VRNA - VERONA PHARMA PLC | Add 4% ($7.0M) | 3.35% | $165.1M | +282.73% | -6.40% | -25.06% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | Add 1% ($1.3M) | 3.26% | $160.6M | +144.84% | -37.51% | +86.72% | |
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 3.07% | $151.5M | -64.81% | -29.72% | -22.23% | ||
| VOR - VOR BIOPHARMA INC | Add 105% ($77.3M) | 3.07% | $151.3M | -95.68% | -14.51% | -58.99% | |
| BIIB - BIOGEN INC | Reduce 43% $(112.1M) | 2.99% | $147.6M | -54.74% | +8.29% | -22.45% | |
| CTKB - CYTEK BIOSCIENCES INC | 2.77% | $136.6M | -71.50% | -37.88% | -25.60% | ||
| LEGN - LEGEND BIOTECH CORP | Add 4% ($4.9M) | 2.47% | $121.6M | -34.85% | +51.37% | +18.07% | |
| RNA - AVIDITY BIOSCIENCES INC | Add 152% ($72.9M) | 2.45% | $121.0M | +51.96% | -51.96% | -42.23% | |
| WVE - WAVE LIFE SCIENCES LTD | 2.44% | $120.4M | +59.20% | -4.95% | -11.08% | ||
| JANX - JANUX THERAPEUTICS INC | 2.32% | $114.2M | +40.36% | -31.80% | -46.15% | ||
| ETNB - 89BIO INC | Add 15% ($14.9M) | 2.31% | $114.0M | -25.67% | +33.36% | -26.94% | |
| PEPG - PEPGEN INC | 2.21% | $108.7M | -91.37% | -8.87% | -14.28% | ||
| IMGN - IMMUNOGEN INC | Add 1% ($558.0K) | 2.20% | $108.4M | +210.60% | |||
| BLU - BELLUS HEALTH INC NEW | Add 9% ($8.8M) | 2.08% | $102.4M | +86.71% | |||
| INBX - INHIBRX INC | New Purchase | 1.93% | $95.0M | ||||
| CLDX - CELLDEX THERAPEUTICS INC NEW | 1.88% | $92.5M | -53.84% | -19.03% | -13.02% | ||
| ITOS - ITEOS THERAPEUTICS INC | 1.75% | $86.3M | -45.74% | -20.58% | -46.32% | ||
| TVTX - TRAVERE THERAPEUTICS INC | Reduce 19% $(19.7M) | 1.70% | $83.8M | -26.98% | -18.95% | -56.65% | |
| COGT - COGENT COMMUNICATIONS HLDGS | Add 49% ($23.0M) | 1.41% | $69.4M | -57.15% | -14.88% | -36.48% | |
| ACRS - ACLARIS THERAPEUTICS INC | 1.40% | $69.3M | -88.00% | -36.00% | -90.54% | ||
| FULC - FULCRUM THERAPEUTICS INC | Add 36% ($18.2M) | 1.40% | $69.2M | -44.10% | -71.38% | -26.10% | |
| ACRV - ACRIVON THERAPEUTICS INC | New Purchase | 1.12% | $55.4M | -94.59% | -39.00% | -82.68% | |
| TYRA - TYRA BIOSCIENCES INC | 1.12% | $55.0M | -18.64% | +5.44% | +52.00% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | 1.07% | $52.8M | -80.44% | +13.35% | -42.78% | ||
| AKRO - AKERO THERAPEUTICS INC | 1.07% | $52.6M | +19.89% | +6.05% | -52.41% | ||
| ELYM - ELIEM THERAPEUTICS INC | 0.98% | $48.3M | -48.33% | +24.17% | +10.42% | ||
| GHRS - GH RESEARCH PLC | 0.97% | $47.6M | +24.85% | +7.92% | -20.79% | ||
| ICVX - ICOSAVAX INC | New Purchase | 0.96% | $47.4M | -10.62% | +56.22% | ||
| RCKT - ROCKET PHARMACEUTICALS INC | Add 14% ($5.9M) | 0.96% | $47.1M | -85.85% | +11.18% | +55.87% | |
| NKTX - NKARTA INC | 0.95% | $46.8M | -64.05% | -8.45% | +105.70% | ||
| NAMS - NEWAMSTERDAM PHARMA COMPANY | New Purchase | 0.88% | $43.6M | +50.08% | -5.12% | +51.31% | |
| RXST - RXSIGHT INC | 0.78% | $38.7M | +7.11% | +62.53% | +284.42% | ||
| ANTX - AN2 THERAPEUTICS INC | 0.73% | $36.0M | -92.13% | -61.35% | -72.70% | ||
| ALPN - ALPINE IMMUNE SCIENCES INC | Add 1% ($299.4K) | 0.66% | $32.3M | +11.01% | +282.59% | ||
| GERN - GERON CORP | Reduce 57% $(41.6M) | 0.63% | $31.3M | -40.91% | +15.15% | -20.83% | |
| DSGN - DESIGN THERAPEUTICS INC | Add 7% ($2.0M) | 0.62% | $30.5M | -39.94% | +2.25% | -61.86% | |
| HLVX - HILLEVAX INC | 0.60% | $29.4M | -87.52% | -11.46% | -4.46% | ||
| KNTE - KINNATE BIOPHARMA INC | 0.53% | $26.0M | -35.40% | -65.66% | |||
| VRDN - VIRIDIAN THERAPEUTICS INC | New Purchase | 0.52% | $25.7M | -56.33% | -28.15% | -41.03% | |
| SPRY - ARS PHARMACEUTICALS INC | New Purchase | 0.52% | $25.7M | +70.13% | -1.14% | -8.10% | |
| CELC - CELCUITY INC | New Purchase | 0.40% | $19.6M | +3.79% | -15.59% | +39.82% | |
| SLDB - SOLID BIOSCIENCES INC | New Purchase | 0.37% | $18.4M | -38.14% | -9.02% | +43.09% | |
| DALS - DA32 LIFE SCNCE | New Purchase | 0.30% | $15.0M | +1.49% | |||
| SCPH - SCPHARMACEUTICALS INC | New Purchase | 0.27% | $13.3M | -48.63% | +44.13% | -29.00% | |
| ELVN - IMARA INC | New Purchase | 0.27% | $13.3M | ||||
| TNYA - TENAYA THERAPEUTICS INC | New Purchase | 0.25% | $12.2M | -83.78% | +110.21% | +73.57% | |
| ACET - ADICET BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| ENTA - ENANTA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| EYPT - EYEPOINT PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| FMTX - FORMA THERAPEUTICS HLDGS INC | Reduce 100% | 0.00% | $0.00 | ||||
| TIL - INSTIL BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| MIST - MILESTONE PHARMACEUTICALS IN | Reduce 100% | 0.00% | $0.00 | ||||
| NSTG - NANOSTRING TECHNOLOGIES | Reduce 100% | 0.00% | $0.00 | ||||
| PMVP - PMV PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| RLMD - RELMADA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| STSA - SATSUMA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| THRD - THIRD HARMONIC BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| VERA - VERA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||